BioNanomatrix Raises $23.3M in Series B Round | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – BioNanomatrix today said it has closed a $23.3 million Series B financing round.

Leading the round was Domain Associates. New investor Gund Investment and existing investors Battelle Ventures, Innovation Valley Partners, and KT Venture Group also participated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.